These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11409037)

  • 21. An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured.
    Jiang X; Smith CS; Petrassi HM; Hammarström P; White JT; Sacchettini JC; Kelly JW
    Biochemistry; 2001 Sep; 40(38):11442-52. PubMed ID: 11560492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 4'-Iodo-4'-deoxydoxorubicin disrupts the fibrillar structure of transthyretin amyloid.
    Palha JA; Ballinari D; Amboldi N; Cardoso I; Fernandes R; Bellotti V; Merlini G; Saraiva MJ
    Am J Pathol; 2000 Jun; 156(6):1919-25. PubMed ID: 10854215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of transthyretin amyloid fibril formation by 2,4-dinitrophenol through tetramer stabilization.
    Raghu P; Reddy GB; Sivakumar B
    Arch Biochem Biophys; 2002 Apr; 400(1):43-7. PubMed ID: 11913969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclodextrin, a novel therapeutic tool for suppressing amyloidogenic transthyretin misfolding in transthyretin-related amyloidosis.
    Jono H; Anno T; Motoyama K; Misumi Y; Tasaki M; Oshima T; Mori Y; Mizuguchi M; Ueda M; Shono M; Obayashi K; Arima H; Ando Y
    Biochem J; 2011 Jul; 437(1):35-42. PubMed ID: 21668413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. D18G transthyretin is monomeric, aggregation prone, and not detectable in plasma and cerebrospinal fluid: a prescription for central nervous system amyloidosis?
    Hammarström P; Sekijima Y; White JT; Wiseman RL; Lim A; Costello CE; Altland K; Garzuly F; Budka H; Kelly JW
    Biochemistry; 2003 Jun; 42(22):6656-63. PubMed ID: 12779320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of transthyretin amyloidogenesis. Antigenic mapping of transthyretin purified from plasma and amyloid fibrils and within in situ tissue localizations.
    Gustavsson A; Engström U; Westermark P
    Am J Pathol; 1994 Jun; 144(6):1301-11. PubMed ID: 8203468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro modelling of familial amyloidotic polyneuropathy allows quantitative detection of transthyretin amyloid fibril-like structures in hepatic derivatives of patient-specific induced pluripotent stem cells.
    Hoepfner J; Kleinsorge M; Papp O; Alfken S; Heiringhoff R; Pich A; Sauer V; Zibert A; Göhring G; Schmidt H; Sgodda M; Cantz T
    Biol Chem; 2017 Jul; 398(8):939-954. PubMed ID: 28051995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review: TTR amyloidosis-structural features leading to protein aggregation and their implications on therapeutic strategies.
    Damas AM; Saraiva MJ
    J Struct Biol; 2000 Jun; 130(2-3):290-9. PubMed ID: 10940233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibiting transthyretin amyloid fibril formation via protein stabilization.
    Miroy GJ; Lai Z; Lashuel HA; Peterson SA; Strang C; Kelly JW
    Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15051-6. PubMed ID: 8986762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural insights into a zinc-dependent pathway leading to Leu55Pro transthyretin amyloid fibrils.
    Castro-Rodrigues AF; Gales L; Saraiva MJ; Damas AM
    Acta Crystallogr D Biol Crystallogr; 2011 Dec; 67(Pt 12):1035-44. PubMed ID: 22120741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cooperative stabilization of transthyretin by clusterin and diflunisal.
    Greene MJ; Klimtchuk ES; Seldin DC; Berk JL; Connors LH
    Biochemistry; 2015 Jan; 54(2):268-78. PubMed ID: 25478940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions amongst plasma retinol-binding protein, transthyretin and their ligands: implications in vitamin A homeostasis and transthyretin amyloidosis.
    Raghu P; Sivakumar B
    Biochim Biophys Acta; 2004 Dec; 1703(1):1-9. PubMed ID: 15588697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type. Definition of molecular abnormality in transthyretin (prealbumin).
    Saraiva MJ; Birken S; Costa PP; Goodman DS
    J Clin Invest; 1984 Jul; 74(1):104-19. PubMed ID: 6736244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between amyloid deposition and intracellular structural changes in familial amyloidotic polyneuropathy.
    Misumi Y; Ueda M; Obayashi K; Jono H; Su Y; Yamashita T; Ohshima T; Ando Y; Uchino M
    Hum Pathol; 2012 Jan; 43(1):96-104. PubMed ID: 21777941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dissociation of amyloid fibrils of alpha-synuclein and transthyretin by pressure reveals their reversible nature and the formation of water-excluded cavities.
    Foguel D; Suarez MC; Ferrão-Gonzales AD; Porto TC; Palmieri L; Einsiedler CM; Andrade LR; Lashuel HA; Lansbury PT; Kelly JW; Silva JL
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9831-6. PubMed ID: 12900507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amyloid formation in rat transthyretin: effect of oxidative stress.
    Tajiri T; Ando Y; Hata K; Kamide K; Hashimoto M; Nakamura M; Terazaki H; Yamashita T; Kai H; Haraoka K; Imasato A; Takechi K; Nakagawa K; Okabe H; Ishizaki T
    Clin Chim Acta; 2002 Sep; 323(1-2):129-37. PubMed ID: 12135814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on plasma transthyretin (prealbumin) in familial amyloidotic polyneuropathy, Portuguese type.
    Saraiva MJ; Costa PP; Goodman DS
    J Lab Clin Med; 1983 Oct; 102(4):590-603. PubMed ID: 6311926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The binding of 2,4-dinitrophenol to wild-type and amyloidogenic transthyretin.
    Morais-de-Sá E; Neto-Silva RM; Pereira PJ; Saraiva MJ; Damas AM
    Acta Crystallogr D Biol Crystallogr; 2006 May; 62(Pt 5):512-9. PubMed ID: 16627944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modeling familial amyloidotic polyneuropathy (Transthyretin V30M) in Drosophila melanogaster.
    Berg I; Thor S; Hammarström P
    Neurodegener Dis; 2009; 6(3):127-38. PubMed ID: 19372706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A look into amyloid formation by transthyretin: aggregation pathway and a novel kinetic model.
    Faria TQ; Almeida ZL; Cruz PF; Jesus CS; Castanheira P; Brito RM
    Phys Chem Chem Phys; 2015 Mar; 17(11):7255-63. PubMed ID: 25694367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.